-
3 days ago | 
healthcarepackaging.com | Joe Darrah
Key Takeaways:· The American Heart Association estimates that more than half of medications prescribed today for patients living with chronic diseases are not taken as directed. · When enrolled in PillPack, customers receive monthly shipments of daily tear-away packets that are personalized and labeled with each medication (and its dosage).
-
1 week ago | 
mddionline.com | Joe Darrah
Employment prospects for professionals in the medtech job market, and perhaps any type of role throughout the healthcare industry, are poised to be more difficult to ascertain this summer as the federal government continues to layoff thousands of agency workers through June.
-
1 month ago | 
mddionline.com | Joe Darrah
Regardless of severity, recovery from stroke or spinal cord injury (SCI) is always a challenging process. This is especially true when the patient’s hands are affected.
-
1 month ago | 
mddionline.com | Joe Darrah
During what has been a rollercoaster-like pattern for more than a decade, market expectations for transcatheter mitral valve replacement (TMVR) devices are continuing to follow an upward trajectory in early 2025.
-
1 month ago | 
packagingdigest.com | Joe Darrah
White House Press Secretary Karoline Leavitt holds up a piece of paper with information about tariff rates while speaking during the daily briefing in the Brady Briefing Room of the White House in Washington, DC, on March 11, 2025. MANDEL NGAN via Getty ImagesAn unpredictable pattern of tariffs on imports kicked into a higher gear internationally this month, and the medtech industry is still trying to navigate an appropriate course in response.
-
1 month ago | 
mddionline.com | Joe Darrah
As Donald Karcher, MD, FCAP, president of the College of American Pathologists (CAP) sees it, not all laboratory-developed tests (LDTs) are created equally. “There are clearly varying degrees of risk to these tests,” he told MD+DI. On the low-risk side of the spectrum are LDTs such as histochemical tests, which typically use dyes on skin cells and tissue to assist in disease diagnosis, and molecular tests that utilize polymerase chain reaction methodology to analyze blood, tissue, and urine.
-
1 month ago | 
mddionline.com | Joe Darrah
An unpredictable pattern of tariffs on imports kicked into a higher gear internationally this month, and the medtech industry is still trying to navigate an appropriate course in response. In the US, an unexpected improvement in the rate of inflation is presumed to be somewhat of a mirage with the most newly initiated tariffs set to increase the prices of goods across the global economy.
-
2 months ago | 
mddionline.com | Joe Darrah
Personalised advertising and content, advertising and content measurement, audience research and services developmentStore and/or access information on a deviceYou can choose how your personal data is used.
-
2 months ago | 
mddionline.com | Joe Darrah
Understandably, COVID-19 does not get much credit for the influence it has had on global business, particularly when it comes to the healthcare industry. But the truth is that the pandemic did expose some inconsistencies and challenges that have existed for some time in the medical device industry from a production and manufacturing standpoint. Within the United States, this is perhaps most evident in the collapse of the supply chain, which was brought on in large part by our reliance on China.
-
2 months ago | 
mddionline.com | Joe Darrah
As the rate and severity of lung disease escalate, industry leaders see the potential for diagnostic medical technologies to play a role in helping to reverse the trend. The current flu season has been challenging for patients and healthcare providers in a variety of ways. According to the Centers for Disease Control and Prevention (CDC), seasonal influenza activity remains elevated across the country during a time when concerns about the effectiveness of this year’s vaccine linger.
